Saturna Capital CORP Buys 930 Shares of UnitedHealth Group Inc (NYSE:UNH)

Saturna Capital CORP lifted its stake in UnitedHealth Group Inc (NYSE:UNH) by 17.3% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 6,305 shares of the healthcare conglomerate’s stock after acquiring an additional 930 shares during the period. Saturna Capital CORP’s holdings in UnitedHealth Group were worth $1,538,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Norges Bank bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $2,343,175,000. Thoroughbred Financial Services LLC lifted its stake in shares of UnitedHealth Group by 25,321.4% in the second quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock valued at $192,287,000 after buying an additional 1,915,308 shares during the period. Sanders Capital LLC lifted its stake in shares of UnitedHealth Group by 50.2% in the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after buying an additional 1,546,140 shares during the period. FMR LLC lifted its stake in shares of UnitedHealth Group by 1.9% in the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after buying an additional 1,232,189 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 9.1% in the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after buying an additional 965,763 shares during the period. Institutional investors and hedge funds own 85.65% of the company’s stock.

UNH has been the subject of several research reports. Bank of America reiterated a “buy” rating and issued a $290.00 target price (down previously from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Raymond James increased their target price on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Friday, July 19th. ValuEngine cut shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. Oppenheimer set a $312.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Citigroup upgraded shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and raised their price target for the stock from $247.00 to $280.00 in a research note on Friday, May 10th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $295.06.

UNH traded up $4.59 during midday trading on Tuesday, reaching $247.80. 1,469,554 shares of the company’s stock were exchanged, compared to its average volume of 3,510,335. The company has a market cap of $235.62 billion, a price-to-earnings ratio of 19.24, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The company’s 50-day moving average is $251.38.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. The firm had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the company earned $3.14 earnings per share. Analysts predict that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.

In other news, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the sale, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 37,000 shares of company stock valued at $9,195,620. Company insiders own 0.82% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What is a short straddle?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.